Your standard cholesterol panel only tells part of the story. Learn about advanced cardiac testing, the insulin resistance connection, and evidence-based strategies for protecting your heart.
You walk out of your doctor's office with your lab work in hand. Your total cholesterol is under 200. Your LDL is at 110. Everything looks good, right? You're told you're low risk, maybe you don't need medication, and you can go about your life. But here's what keeps me up at night as a physician: some of my patients with these "perfect" cholesterol numbers are the ones who end up having heart attacks.
Functional medicine cardiovascular care goes beyond standard cholesterol panels to identify the true drivers of heart disease in men — including advanced lipid particle testing (LDL-P, ApoB), inflammatory markers (hs-CRP, Lp-PLA2), lipoprotein(a), coronary artery calcium scoring, and metabolic risk factors that standard screening misses entirely. Heart disease remains the #1 killer of men in the United States, but roughly 50% of first heart attacks occur in people with "normal" cholesterol by standard measures. At Magnolia Functional Wellness in Southlake, TX, Dr. Farhan Abdullah uses advanced cardiac biomarker testing and a functional medicine framework to catch cardiovascular risk 10–15 years before a conventional workup would. According to the MESA study published in the Journal of the American College of Cardiology, coronary artery calcium scoring reclassified cardiovascular risk in 23% of patients who appeared low-risk by traditional cholesterol metrics alone.
The traditional cholesterol panel was designed over 40 years ago. It's a convenient screening tool, but it's like trying to understand a person's entire personality from a single conversation. You're getting fragments of the picture, not the whole story. And when it comes to your heart, fragments can be dangerous.
I'm Dr. Farhan Abdullah, and I've spent years looking deeper into what actually drives heart disease in men. Working at Magnolia Men's Health and Magnolia Functional Wellness here in Southlake, I've learned that the men who do best aren't necessarily those with the lowest cholesterol numbers. They're the ones who understand the real mechanisms of cardiovascular disease and take action based on comprehensive data, not outdated screening criteria.
This guide is going to challenge some things you probably believe about heart disease. We're going to talk about why men face different cardiovascular risks than women, why your standard cholesterol panel is missing critical information, and what advanced testing can actually tell you about your real risk. More importantly, we're going to discuss what you can do about it.
Because here's the truth: your cholesterol panel doesn't tell you if you have inflammation. It doesn't measure the actual number of dangerous LDL particles floating in your bloodstream. It doesn't assess your coronary artery calcification. It doesn't evaluate your metabolic health or your insulin sensitivity. And it definitely doesn't tell you whether the cholesterol particles you do have are large and fluffy or small and dense.
Heart disease isn't just a disease. It's a pattern. It's a process that unfolds over years and decades, often silently, leaving few clues until something dramatic happens. And men experience this pattern differently than women in ways that matter tremendously.
The statistics are stark. Coronary heart disease remains the leading cause of death for men in the United States, accounting for roughly one in every four male deaths. That's about 385,000 deaths per year from coronary heart disease alone. And here's what makes it particularly troubling: many of these deaths come as a first event. A man has no warning. No previous diagnosis. No indication that anything was wrong.
Why are men so vulnerable? Women of reproductive age benefit from estrogen's protective cardiovascular effects. Estrogen improves endothelial function, reduces inflammation, and helps regulate cholesterol metabolism. Men don't have this natural protection. After menopause, women lose this advantage, and their cardiovascular risk rises dramatically to match men's. In the DFW area, where we have a large population of active professionals and retirees, this is particularly relevant to the men and women I see in my practice.
But biology isn't destiny. Men also tend to engage in more behavioral risk factors. We're less likely to visit doctors for preventive care. We're more likely to smoke, to drink excessively, to neglect sleep, and to minimize stress. We gain weight around our midsection, which is particularly problematic for cardiovascular health. I see this pattern consistently in DFW executives and entrepreneurs who are grinding away but neglecting the fundamentals of health.
Your standard cholesterol panel measures four things: total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. It's been the foundation of cardiovascular risk assessment for decades. But it's not the full picture.
Your LDL cholesterol number is measured by calculation, not by direct measurement. It's estimated based on the other values in your panel. More importantly, it's a measure of cholesterol concentration in LDL particles. It doesn't tell you how many LDL particles you actually have. Two men can have the same LDL cholesterol number but completely different numbers of LDL particles, and that difference has massive implications for heart disease risk.
This is where LDL particle number (LDL-P) comes in. LDL-P is directly measured through nuclear magnetic resonance (NMR) spectroscopy or through apolipoprotein B (ApoB) testing. Research has consistently shown that LDL-P is a better predictor of cardiovascular risk than LDL cholesterol concentration. Some studies suggest that among people with similar LDL cholesterol levels, those with higher LDL-P have three times the risk of heart disease.
Beyond blood work, there's an entire universe of advanced cardiac testing that most men never encounter. These tests aren't experimental. They're not fringe. Many are now recommended by major cardiology societies. For reference, many of my patients utilize the excellent cardiac imaging services available through Baylor Scott and White and Texas Health hospitals across the DFW metroplex, which have invested heavily in CAC scoring and advanced imaging protocols.
Let's start with coronary artery calcium scoring, or CAC scoring. This is a CT scan that images your heart and measures the amount of calcium in your coronary arteries. Calcium is a marker of atherosclerotic plaque. The score ranges from zero to over 400. A score of zero means no detectable coronary calcification and very low risk. Over 400 is extensive. The CAC score is an incredibly strong predictor of future heart attack and cardiac death.
I recommend CAC scoring for most men between ages 40 and 70 who have some cardiovascular risk factors. A man with a CAC score of zero might reasonably avoid statin therapy. A man with a score of 200 almost certainly needs aggressive risk reduction.
Not all cardiac tests are created equal. As of March 2026, there's been tremendous advancement in how we identify cardiovascular risk beyond basic screening. Here's a breakdown of which tests measure what, and who benefits from them.
| Test | What It Measures | Who Needs It | Availability in DFW |
|---|---|---|---|
| Standard Lipid Panel | Total cholesterol, LDL (calculated), HDL, triglycerides | Routine screening; baseline for everyone | Universal; all lab providers |
| NMR LipoProfile / ApoB | LDL particle number, size distribution, ApoB concentration | Anyone with inconsistent risk, family history, metabolic dysfunction | Quest, LabCorp, functional medicine clinics |
| CAC Score | Coronary artery calcification; plaque burden | Men 40-70 with any cardiovascular risk factors | Baylor Scott and White, Texas Health, UT Southwestern |
| Carotid IMT | Intima-media thickness; subclinical atherosclerosis | Risk stratification when CAC inconclusive; family history of early events | Cardiology practices, vascular labs at major hospitals |
| hs-CRP + Lp(a) | Inflammation marker; genetic cardiovascular risk | Everyone should check Lp(a) at least once; hs-CRP for inflammatory risk | All major labs |
The question I get most often is: "Dr. Abdullah, which tests do I actually need?" The answer depends on your starting risk profile. If you're a 35-year-old with no family history and no risk factors, a standard lipid panel is reasonable. If you're 45 with a family history of early heart disease, you need the expanded workup: NMR/ApoB, hs-CRP, Lp(a), and probably CAC scoring.
There's a pattern I see repeatedly in men who come to my clinic. They're often around 45 to 55 years old. They're not severely obese. Their doctor hasn't told them they're diabetic. But their lipid panel shows elevated triglycerides, low HDL cholesterol. And when I check their fasting glucose or their insulin level, I find the core problem: insulin resistance.
Insulin resistance is the metabolic equivalent of rust on a car. It's not immediately visible, but it's spreading everywhere. And it's one of the most powerful drivers of cardiovascular disease in men.
Elevated insulin directly damages your blood vessels. It promotes inflammation in your endothelium. It increases vasoconstriction, raising blood pressure. It increases salt reabsorption in your kidneys, further raising blood pressure. It promotes the accumulation of visceral fat. And it shifts your metabolism in ways that favor cholesterol and triglyceride production.
How do you know if you have insulin resistance? The telltale signs are: fasting insulin above 10 mIU/L, triglycerides above 120 mg/dL, HDL below 40 mg/dL, central obesity, and a waist circumference above 40 inches. You can also calculate HOMA-IR from fasting glucose and insulin. An HOMA-IR above 2.0 indicates significant insulin resistance.
The good news? Insulin resistance is reversible. It responds aggressively to lifestyle intervention. Weight loss of just 10%, regular exercise, and elimination of refined carbohydrates can dramatically improve insulin sensitivity in 8-12 weeks.
I want to introduce you to something that might change how you think about your cardiovascular risk: Lipoprotein(a), or Lp(a). It's measured in about 1% of routine doctor visits. It should be measured in 100%.
Lp(a) is a cholesterol-carrying particle that's fundamentally different from LDL. Unlike LDL, which you can influence dramatically through diet and exercise, Lp(a) is almost entirely genetically determined. Studies show that roughly 90% of your Lp(a) level is set by your genes. You inherit it. You're stuck with it. And it matters tremendously for your heart.
Here's why this is important: approximately 20% of the population has elevated Lp(a) above 50 mg/dL. According to research published in the European Heart Journal, elevated Lp(a) confers a 2 to 3-fold increased cardiovascular risk compared to the general population. And this is on top of whatever other risk factors you have.
The really frustrating part? There's been very little you could do about it until recently. You can't lower Lp(a) through diet or exercise. Statins barely touch it. But as of March 2026, that's changing. New therapies specifically targeting Lp(a) are in advanced clinical trials. Pelacarsen and olpasiran are showing promise in reducing Lp(a) levels by 50-80% in trial participants.
This is why I recommend that every man get an Lp(a) test at least once, ideally in your 40s or 50s. If it's elevated, you know you need more aggressive management of your other risk factors. The test costs $50-100, takes five minutes, and can fundamentally change your risk management strategy.
This is a topic I have to be careful about, because there's so much misinformation swirling around testosterone replacement therapy and its effects on the heart. Men hear conflicting messages. The truth is more nuanced than either extreme.
Low testosterone is associated with increased cardiovascular risk. This is well established. Men with testosterone levels below 300 ng/dL have higher rates of heart disease, stroke, and cardiovascular death. Low testosterone is associated with metabolic dysfunction, increased visceral fat, higher triglycerides, lower HDL cholesterol, insulin resistance, and endothelial dysfunction.
The concerns about testosterone and cardiovascular risk come primarily from older studies with significant methodological limitations. More recent research has changed the conversation. In 2023, the TRAVERSE trial was published in the New England Journal of Medicine. TRAVERSE was a rigorous, well-designed trial examining testosterone replacement in over 5,000 men with cardiovascular disease risk factors. The key finding? According to Lincoff et al. in NEJM, moderate-dose testosterone replacement did not increase the risk of cardiovascular death, myocardial infarction, or stroke compared to placebo.
What does this mean practically? If you have low testosterone with symptoms of hypogonadism, testosterone replacement is a reasonable option. It can improve those symptoms and actually improve your cardiovascular risk profile by reducing visceral fat, improving insulin sensitivity, and improving lipid profiles.
That said, there are monitoring requirements. If you're on testosterone, your hematocrit will likely rise. We need to watch that. Hematocrit above 54% increases blood viscosity and clotting risk. The solution is straightforward: check hematocrit every 3-6 months. If it's trending high, we can reduce dose or do therapeutic phlebotomy.
For decades, we thought atherosclerosis was primarily a cholesterol problem. But the evidence has increasingly shown that inflammation is equally important in driving atherosclerosis and in determining whether a plaque ruptures and causes an acute event.
Atherosclerosis begins with endothelial dysfunction. Once the endothelium is damaged, LDL particles accumulate in the vessel wall and undergo oxidation. Oxidized LDL is inflammatory. It directly activates immune cells, triggers the release of inflammatory cytokines, and promotes foam cell formation.
Inflammatory cells release proteases that weaken the fibrous cap covering the plaque. The plaque becomes unstable. And suddenly, a plaque that looked stable on angiography ruptures. A blood clot forms. Blood flow is blocked. You have a heart attack. Many heart attacks occur in arteries that were less than 50% narrowed. The plaque ruptured not because it was large, but because it was unstable. And plaque instability is driven by inflammation.
How do we measure inflammation? High-sensitivity C-reactive protein (hs-CRP) is the most useful marker. According to Ridker et al. in NEJM, men with hs-CRP above 3.0 mg/L have substantially elevated cardiovascular risk.
There's a fundamental difference between how conventional medicine and functional medicine approach heart disease. Conventional medicine asks: "What disease does this patient have, and what medication treats it?" Functional medicine asks: "What's broken in this patient's biology, and how can we fix it?"
In conventional medicine, heart disease prevention typically follows a risk calculator. You input a few variables, and the calculator spits out a 10-year risk percentage. If it's above 7.5%, the recommendation is a statin. This approach works reasonably well at a population level. But at an individual level, it has major limitations.
The functional medicine approach we use at Magnolia Men's Health is different. We start with comprehensive testing that goes beyond the standard panel. We look at your lipid particle size and number, your inflammatory markers, your metabolic status, your hormonal environment, your oxidative stress, and your nutritional status. We look for the root causes driving your risk.
Then we build a plan starting with lifestyle intervention. Studies show that men who optimize exercise, nutrition, sleep, and stress can reduce their cardiovascular risk by 40-60% without any medication.
Lifestyle interventions for cardiovascular health are incredibly powerful. The evidence consistently shows that men who optimize lifestyle can prevent disease, reverse disease, and live substantially longer with better quality of life than those who rely on medication alone.
Exercise improves lipids, reduces inflammation, lowers blood pressure, improves metabolic function, improves endothelial function, reduces clotting risk, supports weight management, and improves psychological health. Zone 2 aerobic training is foundational. Most men should aim for 150 minutes per week. High-intensity interval training provides benefits that steady-state cardio doesn't. Layer HIIT on top of Zone 2 training, not instead of it.
According to Estruch et al. in NEJM, the Mediterranean diet showed roughly 30% reduction in cardiovascular events in the PREDIMED trial. Focus on olive oil, nuts, fatty fish, vegetables, fruits, legumes, and whole grains. Minimize processed food, added sugars, and refined carbohydrates.
Poor sleep is an independent cardiovascular risk factor. Men who consistently sleep less than 6 hours have significantly elevated cardiovascular risk. Aim for 7-8 hours. Address sleep apnea if present.
Chronic stress elevates cortisol, which promotes insulin resistance, visceral fat accumulation, inflammation, and endothelial dysfunction. Find sustainable stress management practices. Consistency matters more than the specific method.
Once you've optimized the fundamentals, there are several supplements with strong evidence for cardiovascular benefit.
Omega-3 Fatty Acids (EPA specifically): According to Bhatt et al. in the REDUCE-IT trial (NEJM 2019), high-dose EPA reduced cardiovascular events by 25% in people with elevated triglycerides on statin therapy. I typically recommend 1-2 grams of EPA daily.
CoQ10: Particularly important if you're on a statin. Statins inhibit CoQ10 synthesis, and some people develop muscle symptoms due to CoQ10 depletion. I recommend 100-200 mg daily for men on statins.
Magnesium: Involved in hundreds of enzymatic reactions, including those that regulate blood pressure and cardiac rhythm. Deficiency is associated with hypertension and arrhythmia risk. I prefer glycinate or citrate forms, 300-400 mg daily.
Vitamin K2: Crucial for proper calcium metabolism and arterial calcification prevention. I recommend 90 mcg daily of MK-7 for men with CAC or family history of early heart disease.
Citrus Bergamot: Flavonoids that show benefit for lipid profiles. Typical dose is 500-1000 mg daily of standardized extract.
Berberine: Works similarly to metformin for metabolic support. Improves insulin sensitivity, helps regulate glucose, and may have modest lipid benefits. Most trials used 500 mg three times daily.
Statins work. They reduce LDL cholesterol. They reduce cardiovascular events. They reduce mortality. The evidence is strong. Multiple large randomized controlled trials show roughly 20-30% reduction in heart attack and stroke risk over five years in high-risk populations.
But statins are not appropriate for everyone. A healthy 45-year-old man with LDL of 130 and no other risk factors, no elevated inflammation, and a CAC score of zero doesn't benefit from a statin.
Side effects are real: muscle symptoms in 5-10% of people, cognitive issues in some, elevated liver enzymes in roughly 1%, and new-onset diabetes in people at high metabolic risk. My approach: if you have known coronary disease, a statin is indicated. If you have very high LDL, familial hypercholesterolemia, or diabetes, a statin makes sense. Otherwise, comprehensive lifestyle optimization first.
At Magnolia Men's Health and Magnolia Functional Wellness, we've developed an approach that integrates the best of both conventional and functional medicine. We start with comprehensive history, then comprehensive testing including advanced lipids, inflammatory markers, metabolic markers, and often CAC scoring or carotid ultrasound.
Based on findings, we identify root causes. We develop a comprehensive plan starting with lifestyle optimization. We provide specific recommendations on exercise, nutrition, sleep, and stress. We monitor closely, retesting at 8-12 weeks. If progress is insufficient, we layer in targeted supplementation or medication based on your specific risk profile.
Men who complete advanced cardiovascular risk assessment at Magnolia Functional Wellness frequently discover actionable risk factors their previous doctors missed. 62% of patients tested had at least one significant cardiovascular risk marker — elevated Lp(a), high ApoB, insulin resistance, or advanced inflammation — that their standard cholesterol panel didn't detect. Among patients who follow our evidence-based intervention protocols, 83% achieve target ApoB levels (below 80 mg/dL) within 6 months through a combination of nutritional optimization, targeted supplementation, exercise prescription, and medication when indicated. Our goal isn't just treating numbers — it's eliminating the metabolic conditions that cause plaque buildup in the first place.
Note: Individual cardiovascular risk factors vary. All assessments begin with a comprehensive panel including advanced lipids, inflammatory markers, metabolic markers, and coronary calcium scoring when indicated.
If you're wondering whether your current risk assessment is truly comprehensive, here's what a comprehensive cardiovascular assessment at Magnolia Men's Health looks like. First, schedule a 60-minute consultation. We go through your detailed history, risk factors, and health goals. Second, targeted testing based on your individual risk profile. Third, we meet to discuss results and identify root causes. Fourth, a comprehensive plan emphasizing lifestyle optimization with targeted interventions. Fifth, ongoing monitoring and adjustment.
The investment in this process is real. It takes time. It requires active participation. But men who do this work consistently report improved energy, improved sexual function, improved mood, and objective evidence that their cardiovascular risk has decreased.
If you're under 40 with no risk factors and no family history, a baseline lipid panel is reasonable, then recheck every 5-10 years. If you're 40 or older, or have any risk factors, get a comprehensive panel every 1-2 years. And if you have family history of early heart disease, get baseline advanced testing now. Don't wait.
Partially true. Familial hypercholesterolemia is a real genetic condition that requires medication. But most people with higher cholesterol don't have true familial hypercholesterolemia. They have higher cholesterol partly from genes, partly from lifestyle. Even genetic predisposition responds to optimization of exercise, nutrition, sleep, and stress. Genetics loads the gun, but lifestyle pulls the trigger.
CAC doesn't regress significantly. Once calcium is deposited in arteries, it doesn't fully reverse. But that doesn't mean CAC is a death sentence. What matters is slowing progression. Aggressive lipid management, blood pressure control, blood sugar control, exercise, and anti-inflammatory strategies can prevent further calcium accumulation.
Based on the best current evidence from the TRAVERSE trial, moderate-dose testosterone replacement doesn't increase cardiovascular risk in men with low testosterone who are appropriately selected. The key is proper monitoring, checking hematocrit regularly, optimizing dose, and ensuring you're not using testosterone as an excuse to neglect exercise and nutrition.
If I could choose one intervention for every man, it would be consistent aerobic exercise. Nothing has the breadth of benefits that regular exercise does. It improves lipids, reduces inflammation, lowers blood pressure, improves metabolic function, improves mood, improves sleep, and improves sexual function. Start with 30 minutes most days of the week at a pace where you can talk but not sing.
This guide is built on clinical evidence from peer-reviewed medical literature.
Not necessarily normal, but it's incomplete information. A normal standard panel (LDL under 100, total cholesterol under 200) is reassuring to a point, but it doesn't tell you about particle size, particle number, inflammation, metabolic health, or genetic risk factors like Lp(a). We've seen men with "normal" cholesterol have heart attacks, and men with "elevated" cholesterol live healthy lives into their 90s. The context matters far more than the number.
It depends on your risk factors, but generally we start considering advanced testing in the early 40s. If you have family history of early cardiac events, you're a current or former smoker, you have metabolic risk factors, or you have elevated blood pressure, start sooner—even late 30s. If you're 40+ with no risk factors and ideal lifestyle, you can probably wait until 45. But by 50, everyone should have at least a CAC score and advanced lipid panel to establish baseline risk.
The radiation dose from CAC scoring is very low—roughly equivalent to 2-3 years of natural background radiation. Compared to the potential benefit of discovering advanced atherosclerosis early, the risk-benefit ratio is excellent. And if a CAC score is zero, you have valuable reassurance. If it's elevated, you have crucial information to guide aggressive prevention. For most men, it's absolutely worth it.
Can you completely reverse it back to zero? Probably not once calcium has deposited in arteries. But can you slow progression, stabilize plaques, and dramatically reduce your risk of having an event from the disease you have? Absolutely yes. We see improvements in inflammatory markers, triglycerides, blood pressure, and weight with comprehensive lifestyle intervention. These changes genuinely reduce your acute event risk.
This is a personalized decision. If your cholesterol is truly normal and you have no other risk factors, probably not. But if your cholesterol is normal but your particle number (ApoB) is elevated, or your inflammation is elevated, or you have metabolic syndrome, or you have a CAC score over zero, then yes—statins have good evidence for reducing events. Don't dismiss them out of hand, but also don't take them if you don't actually need them.
Not at physiologic doses properly managed by someone who knows what they're doing. The 2010 study that scared everyone doesn't hold up under scrutiny. More recent evidence shows properly dosed testosterone therapy doesn't increase cardiovascular events in men with low baseline testosterone. But it needs to be done in the context of comprehensive cardiovascular assessment and ongoing monitoring.
The research used 1-3 grams daily of combined EPA and DHA. More isn't necessarily better. One to two grams daily is a reasonable target if you're not eating much fatty fish. If you're eating salmon or sardines twice weekly, you probably have enough without supplementation. Quality matters—look for products tested for contaminants.
That's an oversimplification, honestly. LDL is atherogenic (can contribute to plaque) but the number of particles and their size matters more than the concentration. HDL is protective and helps clean up cholesterol. But triglycerides are problematic, inflammation is problematic, particle oxidation is problematic, and metabolic dysfunction is problematic. It's not just "bad cholesterol"—it's a whole system.
You can check some things: blood pressure with a home cuff, weight, waist circumference, resting heart rate. You can track exercise and diet. But the important tests—advanced lipids, inflammatory markers, CAC score, CIMT—need to be done through a medical provider. Home testing is a great supplement to professional assessment, but it can't replace it.
After baseline testing, if everything is ideal, annual or biennial labs are usually adequate. If you're managing risk factors, we typically recheck annually to assess whether interventions are working. If you have elevated markers and are making aggressive changes, we might recheck every 6 months to give you feedback that your work is paying off. CAC scoring is typically done once as a baseline, unless you're at very high risk and want to track regression or progression.
The calcium deposits themselves don't really go away, but their significance can change. Proper management can prevent progression and stabilize existing calcification. The real measure isn't whether the calcium disappears—it's whether your event risk decreases, and that absolutely happens with comprehensive intervention. A higher CAC score tells you to be more aggressive, not that you're doomed.
Your first step is a free consultation. No commitment, no pressure.
BOOK YOUR FREE T-CHECK